Malaria kills at least one million people every year - most of them children in sub-Saharan Africa.

MORU is coordinating "AQUAMAT", a major multi-country clinical trial comparing parenteral quinine and artesunate for the treatment of severe childhood malaria in Africa. This study is currently recruiting at our study site in Mozambique and at eight sites run by our collaborators in seven other countries across Africa.